Senestech, Inc. (NASDAQ:SNES – Get Free Report) major shareholder Glenbrook Capital Management bought 426,000 shares of the company’s stock in a transaction on Thursday, October 15th. The stock was bought at an average cost of $0.77 per share, with a total value of $328,020.00. Following the completion of the purchase, the insider owned 1,505,294 shares of the company’s stock, valued at approximately $1,159,076.38. The trade was a 39.47% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.
Glenbrook Capital Management also recently made the following trade(s):
- On Monday, October 19th, Glenbrook Capital Management bought 376,552 shares of Senestech stock. The shares were bought at an average price of $0.70 per share, for a total transaction of $263,586.40.
- On Friday, October 16th, Glenbrook Capital Management purchased 181,252 shares of Senestech stock. The shares were bought at an average cost of $0.63 per share, for a total transaction of $114,188.76.
- On Friday, August 7th, Glenbrook Capital Management purchased 6,490 shares of Senestech stock. The shares were bought at an average cost of $1.30 per share, for a total transaction of $8,437.00.
- On Thursday, August 6th, Glenbrook Capital Management purchased 15,000 shares of Senestech stock. The stock was bought at an average cost of $1.30 per share, with a total value of $19,500.00.
Senestech Trading Up 8.8%
Shares of Senestech stock opened at $0.75 on Thursday. The company has a debt-to-equity ratio of 0.02, a current ratio of 6.78 and a quick ratio of 5.81. The firm has a 50 day simple moving average of $0.90 and a 200 day simple moving average of $1.32. Senestech, Inc. has a fifty-two week low of $0.55 and a fifty-two week high of $3.90.
Senestech (NASDAQ:SNES – Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported ($0.35) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.37) by $0.02. The firm had revenue of $0.77 million for the quarter, compared to the consensus estimate of $0.60 million. Senestech had a negative return on equity of 71.89% and a negative net margin of 294.73%. On average, analysts anticipate that Senestech, Inc. will post -1.28 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Separately, Weiss Ratings cut Senestech from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, August 11th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Senestech has an average rating of “Sell”.
Read Our Latest Stock Report on Senestech
Institutional Trading of Senestech
An institutional investor recently bought a new position in Senestech stock. Diversify Wealth Management LLC purchased a new stake in Senestech, Inc. (NASDAQ:SNES – Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 19,119 shares of the company’s stock, valued at approximately $31,000. Diversify Wealth Management LLC owned 0.36% of Senestech as of its most recent SEC filing. Hedge funds and other institutional investors own 5.19% of the company’s stock.
About Senestech
SenesTech, Inc is a life sciences company focused on developing fertility-control technologies for managing pest populations. The company’s approach is designed to reduce the reproduction of rodents rather than relying solely on traditional lethal control methods.
SenesTech’s primary product is ContraPest, a liquid bait formulated to target the fertility of both male and female rats. The product is intended for use in settings such as commercial facilities, urban areas, agricultural operations and other locations where rodent populations can create health, safety or economic risks.
Further Reading
- Five stocks we like better than Senestech
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
